摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-N-[1-(3-Quinolylmethanesulfonyl)-4-methyl-2-pentyl]-N-hydroxyformamide | 376387-51-8

中文名称
——
中文别名
——
英文名称
(S)-N-[1-(3-Quinolylmethanesulfonyl)-4-methyl-2-pentyl]-N-hydroxyformamide
英文别名
N-hydroxy-N-[(2S)-4-methyl-1-(quinolin-3-ylmethylsulfonyl)pentan-2-yl]formamide
(S)-N-[1-(3-Quinolylmethanesulfonyl)-4-methyl-2-pentyl]-N-hydroxyformamide化学式
CAS
376387-51-8
化学式
C17H22N2O4S
mdl
——
分子量
350.439
InChiKey
JNTYHTJHIRWKRZ-INIZCTEOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    24
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    96
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
    申请人:——
    公开号:US20040024066A1
    公开(公告)日:2004-02-05
    Compounds of formula (I): 1 R is hydrogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl or heterocyclyl; and R 1 is bicyclyl or heterobicyclyl, are useful in the treatment and prophylaxis of conditions mediated by s-CD23.
    式(I)的化合物:1R是氢,烷基,烯基,炔基,芳基,杂芳基或杂环烷基;和R1是双环烷基或杂双环烷基,对由s-CD23介导的疾病的治疗和预防具有用处。
  • Bicyclyl or heterobicyclylmethanesulfonylanimo-substituted N-hydroxyformamides
    申请人:Best John Desmond
    公开号:US20050288376A1
    公开(公告)日:2005-12-29
    Compounds of formula (I): R is hydrogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl or heterocyclyl; and R 1 is bicyclyl or heterobicyclyl, are useful in the treatment and prophylaxis of conditions mediated by s-CD23.
    式(I)的化合物: 其中R为氢、烷基、烯基、炔基、芳基、杂芳基或杂环基; R1为双环或杂双环基, 可用于治疗和预防由s-CD23介导的疾病。
  • BICYCLYL OR HETEROBICYCLYLMETHANESULFONYLAMINO-SUBSTITUTED N-HYDROXYFORMAMIDES
    申请人:SMITHKLINE BEECHAM PLC
    公开号:EP1289980A1
    公开(公告)日:2003-03-12
  • [EN] BICYCLYL OR HETEROBICYCLYLMETHANESULFONYLAMINO-SUBSTITUTED N-HYDROXYFORMAMIDES<br/>[FR] N-HYDROXYFORMAMIDES A SUBSTITUTION BICYCLYLE OU HETEROBICYCLYLMETHANESULFONYLAMINO
    申请人:SMITHKLINE BEECHAM PLC
    公开号:WO2001090100A1
    公开(公告)日:2001-11-29
    Compounds of formula (I): R is hydrogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl or heterocyclyl; and R1 is bicyclyl or heterobicyclyl, are useful in the treatment and prophylaxis of conditions mediated by s-CD23.
查看更多